0 New compound reverses HIV latency in macaque models
Recently, a research collaboration has managed to reverse HIV latency in infected CD4+ T cells in mouse and macaque models, exposing them to the body’s immune response.
Browsing: Disease Area > Viral
0 Could wearable devices allow real-time flu prediction?
A study has evaluated de-identified data from wearable devices, discovering that this could improve real-time prediction of flu-like illnesses when compared with current surveillance methods.
2 China confirms human-to-human transmission of novel coronavirus
Chinese authorities have confirmed that the virus can be passed from person-to-person, as a fourth person is reported to have died from this infection.
0 Immunological imprinting: first flu strain encountered impacts future immune response
The first strain of flu we encounter during childhood could impact our immune responses to future infections, according to new research.
0 Vesicles released by bacteria may protect against HIV infection in human tissues
Researchers have discovered an association between the spread of HIV and quantity of extracellular vesicles from lactobacilli, suggesting a protective mechanism to inhibit the spread of HIV infection.
0 The best of 2019 – an A–Z of infectious diseases research
Take a look at the research highlights of 2019 as we count down the top infectious disease stories from A to Z!
0 HIV vaccine may be possible through coaxing the immune system to select key antibodies
Using animal models, researchers have discovered that antibodies can be coaxed into proliferating and targeting HIV.
0 Measles cases surge, with young children and infants the most at risk
New estimates from the WHO and the Centers for Diseases Control and Prevention reveal that in 2018, more than 140,000 individuals died from measles worldwide, with most deaths seen in the poorest countries and among infants.
0 Could a common cold virus, RSV, be transmitted from mother to fetus?
The placenta provides essential nourishment and protection to a developing fetus, but new research has suggested that a common cold virus may be able to cross this barrier.
0 Infographic: The pipeline for long-acting HIV formulations
In this infographic we take a look at the long-acting formulations for HIV prevention and treatment currently in the clinical pipeline – from Phase I to approval.
